SCHEMBL3519958

SCHEMBL3519958

O=C1C=CC=C2N=CC=C12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28980646 0.98
SCHEMBL28871737 0.76
Indoline SCHEMBL11158276 0.75 PDPK1 (0.35)
SCHEMBL28779041 0.72 MAOA (0.31)
SCHEMBL6889340 0.71
SCHEMBL9588590 0.70
SCHEMBL16927553 0.70
SCHEMBL30530546 0.70
SCHEMBL1396296 0.69
SCHEMBL4721785 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3310775-A1 3-AMINO-1,5,6,7-TETRAHYDRO-4H-INDOL-4-ONES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-04-25 EP claimed
WO-2016202755-A1 3-AMINO-1,5,6,7-TETRAHYDRO-4H-INDOL-4-ONES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2016-12-22 WO claimed
EP-0980374-A1 PHOSPHODIESTERASE 4-INHIBITING DIAZEPINOINDOLONES PARKE-DAVIS (FR) 2000-02-23 EP claimed
WO-1999050270-A1 PHOSPHODIESTERASE IV-INHIBITING DIAZEPINOINDOLES PARKE-DAVIS (FR) 1999-10-07 WO claimed
WO-1998049169-A1 PHOSPHODIESTERASE 4-INHIBITING DIAZEPINOINDOLONES PARKE-DAVIS (FR) 1998-11-05 WO claimed
JP-6298727-A None JP disclosed
US-12611417-B1 Compositions and methods to inhibit acid-catalyzed dephosphorylation of phosphoryloxytryptamines Convergent Health Sciences LLC: (US) 2026-04-28 US disclosed
US-12503713-B1 Stabilization of tryptamines by denaturing enzymes, optimizing ionization states, and controlling confounding variables Convergent Health Sciences LLC (US) 2025-12-23 US disclosed
US-12497637-B1 Stabilization of tryptamines by denaturing enzymes, optimizing ionization states, and controlling confounding variables Convergent Health Sciences LLC (US) 2025-12-16 US disclosed
CN-120053679-A CD66 c-targeted antibody coupling drug and application thereof in preparation of gastroesophageal junction cancer treatment drug 浙江省肿瘤医院 2025-05-30 CN disclosed
CN-111655258-B Compositions for cryopreservation and methods of use thereof 常青树生物科学公司 2025-03-21 CN disclosed
CN-119587713-A Use of a substance specifically binding ICAM1 for the preparation of a tongue cancer treatment product 中国科学院基础医学与肿瘤研究所(筹) 2025-03-11 CN disclosed
EP-0680964-A1 NEW PIRROLO 3,2-e]INDOL DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND APPLICATIONS UNIVERSIDAD DE SANTIAGO DE COMPOSTELA (ES) 1995-11-08 EP disclosed
JP-H06298727-A PRODUCTION OF CYCLIC AMINES NEW JAPAN CHEM CO LTD 1994-10-25 JP disclosed
EP-0162695-B1 6-OXYGENATED-1,3,,4,5-TETRAHYDROBENZ(CD)INDOL-4-AMINES SMITHKLINE BEECHAM CORPORATION (US) 1990-01-17 EP disclosed
US-4824965-A 4-oxo-4,5,6,7-Tetrahydroindole derivatives BOEHRINGER MANNHEIM GMBH (DE) 1989-04-25 US disclosed
US-4824965-A 4-oxo-4,5,6,7-Tetrahydroindole derivatives BOEHRINGER MANNHEIM GMBH (DE) 1989-04-25 US disclosed
US-4736043-A Process for the preparation of indole derivatives BOEHRINGER MANNEHEIM GMBH (DE) 1988-04-05 US disclosed
EP-0162695-A1 6-Oxygenated-1,3,,4,5-Tetrahydrobenz(cd)indol-4-amines SMITHKLINE BEECHAM CORPORATION (US) 1985-11-27 EP disclosed
US-4079006-A USING A PHOSPHONOMETHYLENE-AMINO CARBOXYLATE MONSANTO COMPANY (US) 1978-03-14 US disclosed